China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2013-02-28 01:30 OrbiMed Raising $500 Million for Asia Healthcare Fund and more... 2013-02-27 01:30 Crystal Pharmatech and Particle Sciences Form CRO Partnership 2013-02-26 01:30 Pfizer Gains China Approval of Kinase-Specific Lung Cancer Drug and more... 2013-02-24 01:30 The Week in Review: Reckitt Benckiser Buys Anhui's Golong Medicine 2013-02-23 01:30 Sihuan Granted SFDA Approval to Test New Diabetes Drug and more... 2013-02-22 01:30 Beijing Double-Crane to Build $43 Million Shanghai Plant 2013-02-21 01:30 chinabiotoday.com 2013-02-20 01:30 Regeneron and Bayer Start Phase III Trial of Macular Edema Drug in China 2013-02-19 01:30 Luye Pharma Completes US Phase II Trial of Cardiovascular TCM 2013-02-17 01:30 Week in Review: Amgen to Build China Presence with Partnerships/M&A 2013-02-16 01:30 China Shenghuo Receives Go-Private Offer from Management 2013-02-15 01:30 Amgen will Use Partnerships and M&A to Enter China Market 2013-02-14 01:30 Shanshi Medical Device In-licenses Tensys Patient Monitoring System for China 2013-02-13 01:30 Celgene Gains SFDA Approval for Multiple Myeloma Treatment 2013-02-12 01:30 OxOnc to Partner with Pfizer on China Cancer Drug Trial 2013-02-10 01:30 Week in Review: Cardinal Health Uses M&A to Add Drug Distribution Reach in China 2013-02-09 01:30 Lee's Pharma Subsidiary In-Licenses Dyax Drug for China Use and more... 2013-02-08 01:30 Zheijang Hisun Nixes Celsion Deal after Drug Fails Trial 2013-02-07 01:30 Cardinal Health Has Acquired Six China Drug Distributors for $120 Million and more... 2013-02-06 01:30 Janssen Pharma Opens R&D Center in Shanghai and more... 2013-02-05 01:30 China's Grandhope Biotech In-licenses Stem Cell Technology from Orthocell 2013-02-03 01:30 Week in Review: Hainan Haiyao Buys SinoMab Stake for $10 Million 2013-02-02 01:30 Luqa Pharma Launches Topical Scar Treatment in China and more... 2013-02-01 01:30 Hainan Haiyao Pays $10 Million for SinoMab Stake   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC